Previous close | 103.55 |
Open | 103.44 |
Bid | 105.46 x 900 |
Ask | 106.60 x 1100 |
Day's range | 103.04 - 106.71 |
52-week range | 44.40 - 106.71 |
Volume | |
Avg. volume | 548,562 |
Market cap | 5.264B |
Beta (5Y monthly) | 1.47 |
PE ratio (TTM) | 40.35 |
EPS (TTM) | 2.63 |
Earnings date | 25 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | 0.80 (0.77%) |
Ex-dividend date | 22 Apr 2024 |
1y target est | 113.00 |
Ashland (ASH) is set to sell its nutraceuticals business to Turnspire Capital Partners, with the deal expected to close in third-quarter 2024.
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
The agreement initially grants Barrick (GOLD) access to about 4,000 square kilometers of consolidated land positions across the country.